Lv1
60 积分 2024-01-01 加入
Advanced hepatocellular carcinoma treatment strategies: Are transarterial approaches leading the way?
29天前
已完结
Hospital variation in Textbook Outcomes following curative-intent resection of hepatocellular carcinoma: an international multi-institutional analysis
30天前
已完结
Focusing on desired outcomes of care after colon cancer resections; hospital variations in ‘textbook outcome’
30天前
已完结
Jianpi-huayu Decotion regulates TREM1/DAP12 pathway to improve the immunosuppressive tumor microenvironment and enhance the anti-hepatocellular carcinoma effect of PD-1 inhibitors
1个月前
已完结
BCLC strategy for prognosis prediction and treatment recommendations: The 2025 update
3个月前
已完结
Artificial intelligence in hepatopancreatobiliary surgery for clinical outcome prediction: current perspective and future direction
4个月前
已完结
Trends in Textbook Outcomes over Time: Are Optimal Outcomes Following Complex Gastrointestinal Surgery for Cancer Increasing?
4个月前
已完结
Using Textbook Outcomes to benchmark practice in pancreatic surgery
4个月前
已完结
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
4个月前
已完结
LBA39 Updated efficacy and safety data from IMbrave050: Phase III study of adjuvant atezolizumab (atezo) + bevacizumab (bev) vs active surveillance in patients (pts) with resected or ablated high-risk hepatocellular carcinoma (HCC)
4个月前
已完结
皖公网安备34019202002308
